Scorpion Capital shorts TransMedics, shares down
Short seller Scorpion Capital disclosed a short position in TransMedics Group Inc (NASDAQ:TMDX) accusing the organ transplant tech. company of fraudulent practices, including kickbacks, billing fraud, ...
TransMedics says claims made by Scorpion Capital ‘have no merit’
Group addressed what we believe are inaccurate and misleading claims made in a short-seller report issued by Scorpion ...
Short Seller Accuses TransMedics Of 'Mafia Style' Scheme, Organ Transplant Company Says Short Seller Manipulating Market
TransMedics faces allegations from Scorpion Capital of fraud and organ trafficking, while the company rebuffs the claims as ...
TransMedics down 10% to $65.39 after Scorpion Capital short report
EST TransMedics (TMDX) down 10% to $65.39 after Scorpion Capital short reportStay Ahead of the Market:Discover outperforming stocks and ...
Taste Test: Arizona Republic reporters try Arizona's iconic scorpion lollipop
Six reporters try out the scorpion lollipop, Arizona's scariest souvenir. “He’s getting red … look at him”: Potentially the ...
TMCnet4h
TMDX Investors Have Opportunity to Join TransMedics Group, Inc. Securities Fraud Investigation with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of TransMedics Group, Inc. ("TransMedics" or "the Company") (NASDAQ ...
Business Wire20h
Rosen Law Firm Encourages TransMedics Group, Inc. Investors to Inquire About Securities Class Action Investigation – TMDX
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of TransMe ...
Mena FN4d
Berman Tabacco Announces Investigation Of Transmedics Group, Inc. (TMDX) Concerning Claims By Scorpion Capital
On January 10, 2025, Bloomberg reported TransMedics shares dropped“as much as 13% after Scorpion Capital said it is short the transplant-therapy company's stock.” ...